Lv1
27 积分 2024-12-12 加入
Design of peptide-based PAC1 antagonists combining molecular dynamics simulations and a biologically relevant cell-based assay
10天前
已完结
Design of peptide-based PAC1 antagonists combining molecular dynamics simulations and a biologically relevant cell-based assay
15天前
已完结
Dissecting the atomic effects of S305 phosphorylation on the aggregation of the core tau peptides of the first intermediate filament
3个月前
已完结
Novel Cyclic Peptide Agonist of High Potency and Selectivity for the Type II Vasoactive Intestinal Peptide Receptor
4个月前
已关闭
Molecular Basis of PAC1R Allosteric Modulation with Lipids in Membranes
4个月前
已关闭
How short peptides disassemble tau fibrils in Alzheimer's disease
5个月前
已完结
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor
6个月前
已完结
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor
6个月前
已完结
皖公网安备34019202002308
